SHL Medical shortlisted for the Pharmapack Awards 2025
SHL Medical is proud to announce that its Elexy™ autoinjector has been shortlisted for the prestigious Pharmapack Awards 2025 in the Delivery and Device Innovation category. This recognition highlights SHL Medical’s commitment to advancing self-injection technologies that empower patients and enhance the treatment experience.
The Pharmapack Awards are highly regarded within the pharmaceutical and drug delivery industries, celebrating advancements that improve patient outcomes and set new standards in drug delivery. Being shortlisted affirms SHL Medical’s leadership in developing pioneering solutions that address the complex needs of modern healthcare.
SHL Medical’s Elexy is a versatile, electromechanical autoinjector designed for multi-use applications. Capable of supporting both pre-filled syringe and cartridge-based drug containers with injection volumes of up to 5.0 mL, Elexy provides pharmaceutical companies with a flexible solution across various stages of drug development. With integrated cellular and RFID connectivity, Elexy facilitates secure data collection to gather comprehensive injection insights and support optimized treatment outcomes.
The winners of the 2025 Pharmapack Awards will be announced at Pharmapack Europe in Paris on January 22–23. SHL Medical will also be exhibiting at Booth #F101, where attendees can explore its comprehensive device portfolio and learn more about the SHL Medical’s commitment to advancing patient-centered solutions.
